CELLCITY
LIVE

Serial Number

79310658

Owner

EVORION Biotechnologies GmbH

Attorney

Leigh Ann Lindquist

Filing Date

Feb 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CELLCITY Trademark

Serial Number: 79310658 • Registration: 7088741

CELLCITY is a trademark filed by EVORION Biotechnologies GmbH on February 23, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

EVORION Biotechnologies GmbH (3 trademarks)

Mendelstr. 17

Entity Type: 16

Trademark Details

Filing Date

February 23, 2021

Registration Date

June 27, 2023

Published for Opposition

January 31, 2023

Cancellation Date

November 11, 2025

Goods & Services

Devices for medical and veterinary purposes, namely, instruments for medical or veterinary diagnostic purposes, in particular for the diagnosis of infectious diseases, tumor diseases, allergies, autoimmune diseases, cardiovascular diseases and metabolic diseases; diagnostic, examination and monitoring devices for medical and veterinary purposes, in particular cell culture chambers for medical and veterinary purposes; artificial organs, namely, artificial hearts, artificial livers, artificial kidneys, artificial spleens, artificial thyroids, artificial dermal tissue, artificial subcutaneous tissue, artificial digestive organs, and implants consisting of artificial materials and of artificial tissue

Scientific apparatus, instruments and devices, namely, microfluidic systems for bio-sensing and diagnostic purposes consisting of microfluidic chips, biochips, cell culture chips, microchips, biosensors, micropumps, micromixers, microfilters, microseparators, microconcentrators, micro droplet devices and microtraps for hydrodynamic trapping of particles; scientific apparatus, instruments and devices, namely, cell culture plates, cell culture chips, microfluidic chips for cells, biochips, nanoliter dispensing pumps, vacuum pumps for laboratory use, chromatography columns, laboratory robots and spare parts and equipment therefor, in particular, pre-recorded flash memory and USB cards featuring automation of detection, testing, measurement and analysis methods in laboratories, microplates, pipettes, pipette tips, pipette tip holders, test vessels, reagent holders, flasks, test tube holders, holders for microvessels, magnetic syringes, biochips, thermocyclers, homogenizers, and vacuum valves, all for scientific or laboratory use; scientific apparatus, instruments and devices, in particular electronic control units for controlling the aforementioned microfluidic systems; incubators and temperature chambers all for laboratory purposes; laboratory systems comprising electronic control units and incubators or temperature chambers as well as microfluidic systems consisting of microfluidic chips, biochips, cell culture chips, microchips, biosensors, micropumps, micromixers, microfilters, microseparators, microconcentrators and micro droplet devices; all the foregoing goods, in particular for scientific and laboratory research, development and investigation purposes, namely, for sample preparation, modification and manipulation of cells, and for labeling, separation, isolation, purification, amplification and/or analysis of biopolymers being nucleic acids, proteins, macromolecules and biologically active substances being proteins and/or nucleic acids from biological or biochemical sample material; measuring apparatuses and instruments for food diagnostics, namely, diagnostic apparatus for detection of microorganisms, heavy metals, allergens, additives, biotoxins, pesticides residues, chemical substances and nutritional values in different food samples

Biological, chemical, biochemical and biotechnological products for industrial and scientific purposes, in particular nucleic acids, enzymes, polymerases, fluorescent dyes and molecular labels, molecular probes being biochemical reagents, buffers, aqueous and non-aqueous solutions of alcohols and/or salts, distilled or purified water, silicates, magnetic nanoparticles, and column materials in the nature of chromatography chemicals; reagents and solvents for scientific and industrial purposes, namely, nucleic acids, enzymes, proteins, macromolecules and biologically active substances, for sample preparation, purification, lysis, modification and/or manipulation of cells as well as for performing labeling, separation, isolation, purification, amplification and/or analysis methods for biopolymers; kits for laboratory or research use containing biological, chemical, biochemical and/or biotechnological products, namely, nucleic acids, enzymes, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material, for sample preparation, purification, lysis, modification and manipulation of cells as well as for performing labeling, separation, isolation, purification, amplification and/or analysis methods for biopolymers

Scientific and technological services, namely, scientific research and development and product research and development in the field of laboratory diagnostics, chemistry, genetics, biology, biotechnology and biochemistry; laboratory analysis and research in the field of DNA, RNA and protein detection and analysis for use in * medical diagnostics, namely, * diagnosing infectious diseases, tumor diseases, allergies, autoimmune diseases, cardiovascular diseases and metabolic diseases

Diagnostic preparations for medical and veterinary purposes, in particular for the diagnosis of infectious diseases, tumor diseases, allergies, autoimmune diseases, cardiovascular diseases and metabolic diseases; products for human medical and/or veterinary purposes, namely, diagnostic preparations for medical and veterinary purposes, enzymes, cells, cultures of micro-organisms and cultures of cells; diagnostic preparations for medical and/or veterinary purposes, namely, nucleic acids, enzymes, polymerases, fluorescent dyes and molecular labels, molecular probes being biochemical reagents, buffers, aqueous and non-aqueous solutions of alcohols and/or salts, distilled or purified water, silicates, magnetic nanoparticles, column materials in the nature of chromatography chemicals, biological, chemical, biochemical and biotechnological preparations; kits for medical diagnostic or veterinary diagnostic purposes, containing diagnostic biological, chemical, biochemical and/or biotechnological agents, preparations and substances, namely, nucleic acids, enzymes, proteins, macromolecules and biologically active substances used for sample preparation, purification, lysis, modification and/or manipulation of cells as well as for labeling, separation, isolation, purification, amplification and/or analysis of biopolymers, all for use in disease detection

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Feb 19, 2026 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Jan 20, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 20, 2026 XXCR
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 30, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Nov 30, 2025 DETH
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 10, 2025 INPR
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Jan 22, 2024 NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Jan 16, 2024 NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Jan 16, 2024 NURC
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 7, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 14, 2023 FICS
FINAL DISPOSITION PROCESSED
Dec 14, 2023 FIMP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Dec 14, 2023 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Dec 14, 2023 COC.
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 27, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 27, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 27, 2023 R.PR
LIMITATION OF GOODS RECEIVED FROM IB
Jun 16, 2023 LIMG
WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST
May 17, 2023 ISMR
NOTIFICATION PROCESSED BY IB
May 16, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 16, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 16, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 26, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 26, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2023 NONP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Apr 12, 2023 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 1, 2023 ETOF
NOTIFICATION PROCESSED BY IB
Jan 31, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 31, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 31, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 11, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 11, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 11, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 29, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 30, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 30, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 30, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 30, 2022 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 7, 2022 OPNX
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 4, 2022 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 19, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 19, 2022 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 24, 2022 GNFN
FINAL REFUSAL E-MAILED
May 24, 2022 GNFR
FINAL REFUSAL WRITTEN
May 24, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2022 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 6, 2022 TROA
REFUSAL PROCESSED BY IB
Oct 30, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 7, 2021 RFCS
REFUSAL PROCESSED BY MPU
Oct 7, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 24, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 23, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 17, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
May 21, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 13, 2021 REPR